Summary:
- The article discusses the growing number of biotech and pharmaceutical deals between China and global companies, particularly with Merck.
- It highlights that China's biopharmaceutical market is rapidly expanding, driven by factors like an aging population and government support for the industry.
- The article notes that global companies are increasingly seeking partnerships and collaborations with Chinese firms to access the growing market and leverage China's scientific capabilities.